The global normal saline for parenteral use market was valued at USD 3.38 Billion in 2024 and is projected to reach USD 5.77 Billion by 2034, growing at a CAGR of 5.50%. Growth is driven by the rising prevalence of chronic diseases requiring intravenous fluid therapy worldwide. https://www.expertmarketresearch.com/reports/normal-saline-for-parenteral-use-market